Literature DB >> 15357793

Acquired inhibitor of factor V: first report in China and literature review.

L Lu1, Y Liu, J Wei, L Zhang, L Zhang, R Yang.   

Abstract

We reported a 51-year-old man who developed a severe haematuria with a prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT). Laboratory evaluation revealed the presence of specific factor V inhibitors. No underlying diseases and associated conditions have been identified. The patient improved after immunosuppressive therapy. However, the FV level remained low, indicating incomplete inhibitor eradication. The clinical course of our patient was consistent with the observations by others that FV inhibitor can be persistent for months or years.

Entities:  

Mesh:

Year:  2004        PMID: 15357793     DOI: 10.1111/j.1365-2516.2004.01014.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  2 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

2.  Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.

Authors:  Qing-ya Cui; Hong-shi Shen; Tian-qin Wu; Hai-fei Chen; Zi-qiang Yu; Zhao-yue Wang
Journal:  Drug Des Devel Ther       Date:  2015-04-24       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.